Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-vascular Endothelial Growth Factor”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Large-scale testing (Phase 3)Study completedNCT06270836
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

Who this might be right for
Diabetic Retinopathy
Kodiak Sciences Inc 255
Testing effectiveness (Phase 2)Looking for participantsNCT07111520
What this trial is testing

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
BioNTech SE 880
Large-scale testing (Phase 3)Study completedNCT00911170
What this trial is testing

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Who this might be right for
CancerColon CancerColorectal Cancer+5 more
Amgen 847
Not applicableStudy completedNCT05640895
What this trial is testing

Intravitreal Injection Site and Perceived Pain

Who this might be right for
Pain
The University of Texas Medical Branch, Galveston 53
Large-scale testing (Phase 3)Study completedNCT03321513
What this trial is testing

DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME

Who this might be right for
Diabetic Macular Edema
Jaeb Center for Health Research 270
Not applicableStudy completedNCT06710951
What this trial is testing

Effect of Povidone-iodine 5% Vs 1% on the Ocular Surface in Intravitreal Injections of Anti-VEGF

Who this might be right for
Dry Eye
José Gerardo García Aguirre 88
Not applicableStudy completedNCT00978926
What this trial is testing

The Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancy
National University Hospital, Singapore
Testing effectiveness (Phase 2)Study completedNCT01676714
What this trial is testing

Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer

Who this might be right for
Non-Small Cell Lung CancerColorectal Cancer
University of California, Davis 10
Large-scale testing (Phase 3)Study completedNCT03172299
What this trial is testing

Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma

Who this might be right for
Ocular Melanoma
Centre Hospitalier Universitaire de Nice 57
Early research (Phase 1)Ended earlyNCT01004822
What this trial is testing

A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 31
Not applicableEnded earlyNCT00709657
What this trial is testing

The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion

Who this might be right for
Macular DegenerationRegional Blood FlowVascular Endothelial Growth Factor
Medical University of Vienna 8
Early research (Phase 1)Looking for participantsNCT04777994
What this trial is testing

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
Advanced Solid Tumor Cancer
Calico Life Sciences LLC 248
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Large-scale testing (Phase 3)Ended earlyNCT04611152
What this trial is testing

A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Kodiak Sciences Inc 460
Not applicableUnknownNCT05759884
What this trial is testing

Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema

Who this might be right for
Macular Edema Due to Type 2 Diabetes Mellitus
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Post-approval studies (Phase 4)Study completedNCT03590444
What this trial is testing

Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser

Who this might be right for
Diabetic Retinal Edema
Hospital Hietzing 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07301775
What this trial is testing

Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery

Who this might be right for
Diabetic Retinopathy (DR)Diabetic Macular Edema (DME)Cataract+2 more
Ahmad Zeeshan Jamil 166
Testing effectiveness (Phase 2)Ended earlyNCT04051957
What this trial is testing

Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury

Who this might be right for
Kidney InjuryProteinuriaHypertension
The University of Texas Health Science Center, Houston 9
Testing effectiveness (Phase 2)Study completedNCT02712008
What this trial is testing

Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Regeneron Pharmaceuticals 302
Post-approval studies (Phase 4)Study completedNCT02036424
What this trial is testing

Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Raj K. Maturi, MD 45
Next Page